v3.26.3
ACQUIRED IN PROCESS RESEARCH AND DEVELOPMENT (Details Narrative) - Gensignia Life Sciences Inc [Member]
1 Months Ended
Mar. 31, 2025
$ / shares
shares
Defined Benefit Plan Disclosure [Line Items]  
Shares issued | shares 3,750,000
Shares price | $ / shares $ 0.40